8:00 AM ET
8-K
Leadership Change
NextCure Leadership Change
NextCure, Inc. announced that Chief Medical Officer Dr. Udayan Guha will be terminated effective October 31, 2026. The departure is in contemplation of the company's pending merger with Avere Therapeutics, Inc. Dr. Guha will receive severance benefits consistent with a termination without cause, including enhanced benefits if the merger closes.